NCI-H1672細(xì)胞
生長狀態(tài)： 懸浮生長，多細(xì)胞聚集
是否是腫瘤細(xì)胞： 1
物種來源： 人
年限： stage L
ATCC Number： CRL-5886?
運輸方式： 凍存運輸
相關(guān)**： 小細(xì)胞肺癌
器官來源： 肺
數(shù)量： 大量
Designations: NCI-H1672 [H1672]
Depositors: AF Gazdar, JD Minna
NCI-H1672細(xì)胞Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension, multicell aggregates
Organism: Homo sapiens
Morphology:
Source: Organ: lung
Tumor Stage: stage L
Disease: carcinoma; classic small cell lung cancer
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Restrictions: NCI-H1672細(xì)胞The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 699-8056, FAX (214) 688-7233.
Isolation: Isolation date: July, 1987
DNA Profile (STR): Amelogenin: X,Y
CSF1PO: 10,11
D13S317: 11
D16S539: 11
D5S818: 11,13
D7S820: 10
THO1: 10
TPOX: 11
vWA: 17
Age: 58 years
Gender: male
Ethnicity: Caucasian
Comments: NCI-H1672細(xì)胞The line was established in July 1987.
The patient was a smoker.
138 pack years.
A lymphoblastoid line from the same patient is available as ATCC CRL-5959.
Propagation: ATCC complete growth medium: HITES medium supplemented with 5% fetal bovine serum
The base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium
0.005 mg/ml Insulin
0.01 mg/ml Transferrin
30nM Sodium selenite (final conc.)
10 nM Hydrocortisone (final conc.)
10 nM beta-estradiol (final conc.)
extra 2mM L-glutamine (for final conc. of 4.5 mM)
5% fetal bovine serum (final conc.)
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
Subculturing: Protocol: Cultures can be maintained by the addition of fresh medium. Cells grow as floating aggregates of round cell clusters.
Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density)
Preservation: Freeze medium: Complete growth medium supplemented with an additional 15% fetal bovine serum and 5% DMSO
Storage temperature: liquid nitrogen vapor phase
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006
recommended serum:ATCC 30-2020
normal (or near-normal) cell line established from the same patient:ATCC CRL-5959
References: 23570: . NCI-H1672細(xì)胞NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.
